Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

The Current Evidence-Based Medicine Landscape

The Current Evidence-Based Medicine Landscape

This reference guide identifies and documents all relevant organizations, activities, proposals, and key individuals associated with the evidence movement in the U.S., including anything of note under the rubric of evidence-based medicine (EBM), comparative effectiveness, and health (or medical) technology assessment (HTA), among others.

Blog Post

CER Tweets of the Week (June 3-7, 2013)

The Patient-Centered Outcomes Research Institute (PCORI) generated buzz on Twitter this week with the announcement of the winners of the PCORI...
Newsletter Volume

E.V.I.dently May 2013

Message From NPCThe Role of Pharmaceuticals in Health Insurance ExchangesOne of the most pressing issues in the implementation of the Affordable Care...
YouTube Videos

Why Real-World Evidence Matters

National Pharmaceutical Council Director of Comparative Effectiveness Research Dr. Jennifer Graff explains the concept of real-world evidence (what...
Blog Post

CER Collaborative: Providing the Tools for Better Formulary Decisions

National Pharmaceutical Council Chief Science Officer Robert Dubois, MD, PhD, and Director of Comparative Effectiveness Research Jennifer Graff,...
Press Release

NPC Welcomes Dr. Bryan Luce as PCORI Chief Science Officer

WASHINGTON, DC (April 24, 2013) The National Pharmaceutical Council today welcomed the news that the Patient-Centered Outcomes Research Institute (...
Press Release

NPC Survey Shows Health Care Stakeholders Continue to Show Optimism About Future Role of Comparative Effectiveness Research

(Washington, DC, March 19, 2013)—As the implementation of the Affordable Care Act (ACA) picks up speed, a new survey shows that health care...
Press Release

National Pharmaceutical Council Welcomes Amgen as Its Newest Member

Washington, D.C. (January 16, 2013)—The National Pharmaceutical Council (NPC) today welcomed biotechnology pioneer Amgen as its newest member. Joshua...
Press Release

National Pharmaceutical Council Comments on PCORI Approval of Research Methodology Standards

Washington, DC (November 19, 2012)—The National Pharmaceutical Council (NPC) today commented on the Patient-Centered Outcomes Research Institute’s (...
Commentary and Testimony Page

The State of CER and the Environment for Health Care Decision Making

This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (CER), “The State of Comparative...
Commentary and Testimony Page

Keeping Our Eye on the CER Ball

Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington will focus on the federal budget....
Commentary and Testimony Page

Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?

A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...
Commentary and Testimony Page

Living Up to Its Name? The Role of Patient-Centered Research

Anyone who has ever received bad news from his or her health care provider or held a loved one’s hand when a diagnosis was delivered can understand...
YouTube Videos

Why Real-World Evidence Matters

National Pharmaceutical Council Director of Comparative Effectiveness Research Dr. Jennifer Graff explains the concept of real-world evidence (what...
YouTube Videos

CER Collaborative: Assessing Evidence and Informing Decision-Making

National Pharmaceutical Council (NPC) Director of Comparative Effectiveness Research Dr. Jennifer Graff discusses an initiative designed to help...
YouTube Videos

The State of Comparative Effectiveness Research and the Environment for Health Care Decision Making

NPC discusses the findings from its third annual survey that gauges the attitudes and expectations of comparative effectiveness research (CER) among...
YouTube Videos

Debunking the Myth of the Average Patient

National Pharmaceutical Council Chief Science Officer Dr. Robert Dubois debunks the myth of the "average" patient and explains the concept of...
Blog Post

CER Tweets of the Week (June 3-7, 2013)

The Patient-Centered Outcomes Research Institute (PCORI) generated buzz on Twitter this week with the announcement of the winners of the PCORI...
Blog Post

CER Collaborative: Providing the Tools for Better Formulary Decisions

National Pharmaceutical Council Chief Science Officer Robert Dubois, MD, PhD, and Director of Comparative Effectiveness Research Jennifer Graff,...
Blog Post

CER Tweets of the Week (Apr. 29 – May 3, 2013)

Conversations on Twitter about evidence and comparative effectiveness research highlighted the Agency for Healthcare Research and Quality’s call for...
Blog Post

CER Tweets of the Week (Apr. 22-26, 2013)

A plan by the Patient-Centered Outcomes Research Institute (PCORI) to allocate $68 million to develop a network of research centers was widely...

Research

Pharmaceutical Benefits Under State Medical Assistance Programs, 1973

This edition of the Pharmaceutical Benefits Under St

Journal of CER

Principles for Planning and Conducting Comparative Effectiveness Research

A group of leading researchers developed a set of 13 best practice principles that could help to...

Explaining Drug Spending Trends: Does Perception Match Reality?

Using large claims databases from managed care and e

  •  
  • 1 of 11
  • >

Commentary & Testimony